Support our online development, and advance our onground research initiatives in free market economics, as we seek to showcase the brightest Next-Gen minds.
THE ME-P DISCLAIMER: Posts, comments and opinions do not necessarily represent iMBA, Inc., but become our property after submission. Copyright © 2006 to-date. iMBA, Inc allows colleges, universities, medical and financial professionals and related clinics, hospitals and non-profit healthcare organizations to distribute our proprietary essays, photos, videos, audios and other documents; etc. However, please review copyright and usage information for each individual asset before submission to us, and/or placement on your publication or web site. Attestation references, citations and/or back-links are required. All other assets are property of the individual copyright holder.
Nemeroff Resigns Psychiatry Chairmanship
By Staff Reporters
Senator Charles Grassley’s (R-Iowa) investigation into conflicts of interest among doctors has led Charles Nemeroff to step down from his chairmanship of Emory University’s psychiatry department. Nemeroff, a late career MD-PhD and prominent researcher in clinical depression, has been hit by a steady stream of criticism since Grassley alleged he failed to disclose hundreds of thousands in payments from GlaxoSmithKline.
Unreported Income Galore
According to the Wall Street Journal, December 23, 2008 Emory’s investigation turned up more than $800,000 in income from Glaxo that Nemeroff didn’t report to the university, for more than 250 speaking engagements over six years.
As a mea culpa, Emory won’t ask for research grants or other contracts involving Nemeroff for two years – a voluntary ban that would apply to National Institutes of Health [NIH] funding.
Assessment
Is this a black-eye for Emory University, or just a slight hematoma? Are other “shoes to drop?”
Conclusion
Your thoughts and comments on this Medical Executive-Post are appreciated.
Speaker:If you need a moderator or speaker for an upcoming event, Dr. David E. Marcinko; MBA – Publisher-in-Chief of the Medical Executive-Post – is available for seminar or speaking engagements. Contact: MarcinkoAdvisors@msn.com
Subscribe Now:Did you like this Medical Executive-Post, or find it helpful, interesting and informative? Want to get the latest ME-Ps delivered to your email box each morning? Just subscribe using the link below. You can unsubscribe at any time. Security is assured.
Link: http://feeds.feedburner.com/HealthcareFinancialsthePostForcxos
Share this:
Filed under: Drugs and Pharma, Ethics, Information Technology | Tagged: Nemeroff |
The Leading Business Education Network for Doctors, Financial Advisors and Health Industry Consultants 
According to FiercePharma and Tracy Staton on June 10th 2009, yet another psychiatrist has found his way into Sen. Charles Grassley’s interrogation chamber. And this time, the doctor’s employer moved quickly with a reprimand: Emory University disciplined Dr. Zachary Stowe, a prominent psychiatrist who was being paid by GlaxoSmithKline at the same time he was conducting federal research about the use of antidepressants in pregnant women. Stowe hadn’t disclosed his payments from Glaxo, which amounted to at least $250,000 in 2007 and 2008.
Grassley wrote Emory earlier this month, saying that records he’d obtained from Glaxo–which makes the antidepressant Paxil–detailed those payments, which included fees for at least 95 promotional talks on the drugmaker’s behalf, the Wall Street Journal reported. Meanwhile, Stowe was listed as primary investigator on at least three grants from NIH that involve antidepressant use in pregnant women. NIH requires reporting of conflicts of interest among researchers working under its grants.
In a statement, Emory said Dr. Stowe had come forward to acknowledge his undisclosed conflicts of interest. Perhaps the doctor learned something from the experience of Dr. Charles Nemeroff, another Emory psychiatrist who stepped down as chairman of the department last year after failing to report more than $800,000 received from Glaxo from 2000 to 2006.
Nemeroff’s conduct is now under investigation by the HHS inspector general; he remains on Emory’s faculty and maintains that he had acted in good faith to follow the disclosure rules as he understood them.
Link: http://online.wsj.com/article/SB124460466072501139.html
First the SEC, banks and insurance companies dropped the ethical ball; and now it may be the doctors …. surprising?
Jade
LikeLike
Ghostwriting Controversy
The American Psychiatric Association (APA) is having a hard time harnessing a controversy brought by muckrackers, its own members, and reported in The Chronicle of Higher Education.
http://www.miwatch.org/2011/04/apas_ghostwriting_controversy_grows.html
Allegations persist that a book published under its imprint was principally ghostwritten. And neither the authors, nor the association, nor the company involved, Scientific Therapeutics Inc. (STI), have satisfied doubts that Alan Schatzberg and Charles Nemeroff, were actually the “authors” as the term is conventionally understood.
Bud
LikeLike
Just How Close Was Nemeroff With Glaxo?
For all the chatter and concern about financial relationships between academia and industry, the case involving Charles Nemeroff [above] made him a poster boy for the controversy.
http://www.pharmalot.com/2011/09/just-how-close-was-nemeroff-with-glaxo/?utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+Pharmalot+%28Pharmalot%29
Kirk
LikeLike
Emory Healthcare says 315,000 hospital patient files are missing
According to Carrie Teegardin of the The Atlanta Journal-Constitution, Emory Healthcare just announced that it cannot locate 10 computer discs containing personal and health information of 315,000 patients.
The missing discs held back-up data that included information on all patients who had surgery at Emory University Hospital, Emory University Midtown and The Emory Clinic Ambulatory Surgery Center between September 1990 and April 2007.
The discs contained protected health information, including patient names, along with the diagnosis, the name of the surgical procedure and the surgeon.
http://www.ajc.com/news/emory-says-315-000-1421327.html
Approximately 228,000 of the patient records also included Social Security numbers.
Ann Miller RN MHA
[Executive-Director]
LikeLike
Emory Healthcare loses records for 315K patients, including CEO’s
Ann – More bad news here in Atlanta.
http://www.emoryhealthcare.org/protection/
Venetia
LikeLike